Objective
RNA-binding proteins are implicated across a wide spectrum of human genetic disorders, with molecular mechanisms ranging from aggregation of proteins and RNAs to defects in splicing and translation. Examples include heterogeneous and life-threatening genetic disorders such as Diamond-Blackfan anaemia, spinocerebellar ataxia and amyotrophic lateral sclerosis (ALS) among others.
The DeepRNA project targets genetic diseases via disease-associated variants in the human transcriptome and is enabled by recent data on expression quantitative trait loci (eQTLs) and experimentally determined RNA-protein and RNA-RNA interactions. The data will be complemented with high-quality RNA-protein interaction predictions carried out in the host group that has a strong track record in computing and validating RNA-protein associations.
To my knowledge the use of eQTL variants to study RNA-protein interactions is a novel approach and is useful for developing new tools for personalised medicine. My approach will expand the human interactome in a genome-wide manner beyond experimental data, which is currently available for only 352 of the 1,542 recently described RNA-binding proteins. Complementing experimentally determined interactions with predictions will allow me to expand my analyses of the human interactome to the genomic scale while maintaining accuracy, by using the experimental dataset as a gold standard. I will employ methods such as graph partitioning and graph neural network encoding to rationalise the effects of disease-associated variants on the human interaction network, and make quantitative predictions of polymorphisms associated with genetic diseases, thereby aiding personalised medicine.
I am confident that this fellowship will equip me with the domain knowledge, independence and transferrable skills to confidently and creatively build an interdisciplinary, globally recognised research team within Europe that will focus on medically relevant human signalling systems.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences health sciences personalized medicine
- natural sciences biological sciences genetics RNA
- natural sciences computer and information sciences artificial intelligence machine learning
- natural sciences computer and information sciences artificial intelligence computational intelligence
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
08003 Barcelona
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.